The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Miracle Healing Peptide or Hidden Danger? FDA to weigh easing limits on unproven peptides BPC 157: Miracle Healing Peptide or Hidden Danger? Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest